Gunther Birznieks, SVP, Business Development at Vanda Pharmaceuticals Inc. (VNDA), sold 8,525 shares at $18.72 ($160K) on 2018-03-01, disclosed to the SEC on 2018-03-02.
Open-market sale of $160k VNDA by SVP, Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VNDA | SELL | 2023-03-06 | $209K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $305K | — | Filing → |
| VNDA | SELL | 2021-03-03 | $748K | — | Filing → |